| Theresa Cambre Amerson, MD | |
|
120 Healthplex Way, Apex, NC 27502-8403 | |
| (919) 350-0550 | |
| Not Available |
| Full Name | Theresa Cambre Amerson |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 19 Years |
| Location | 120 Healthplex Way, Apex, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518094093 | NPI | - | NPPES |
| 1518094093 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | SC27976 (South Carolina) | Secondary |
| 207R00000X | Internal Medicine | 2008-00570 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wakemed, Raleigh Campus | Raleigh, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wake Specialty Physicians Llc | 7416006085 | 144 |
News Archive
A team of researchers has developed a method to produce cells that kill tumour cells in the lab and prevent tumours forming in mouse models of cancer. Although the current work is in cells and mouse, if the research transfers to human biology, the new type of cell could be a new source for cell-based anticancer therapies.
Yet despite the care the administration took in establishing incentives and safeguards, even some of Obamacare's most committed backers are wondering whether the experiment will work as advertised -; or, like Harvard's P.P.O., go off the rails along the way. Adverse selection is perhaps the direst threat. ... Healthier Americans will probably flock to cheaper bronze plans. And insurers will vie to enroll the healthy. In some states, big insurers have chosen not to participate in exchanges to avoid their strictures. On the outside, they could still sell cheap plans to skim off the healthy and avoid a rule that insurers on the exchanges must also offer more generous silver and gold plans (Eduardo Porter, 8/7).
Patients with advanced cancer are to test a therapy aimed at reducing their symptoms and improving quality of life.
In a new, multisite study of deaf children with cochlear implants, UT Dallas researchers have found that children with either no exposure or limited exposure to sign language end up with better auditory, speaking and reading skills later.
› Verified 5 days ago
| Entity Name | Advance Community Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245223783 PECOS PAC ID: 3577471697 Enrollment ID: O20040824000695 |
News Archive
A team of researchers has developed a method to produce cells that kill tumour cells in the lab and prevent tumours forming in mouse models of cancer. Although the current work is in cells and mouse, if the research transfers to human biology, the new type of cell could be a new source for cell-based anticancer therapies.
Yet despite the care the administration took in establishing incentives and safeguards, even some of Obamacare's most committed backers are wondering whether the experiment will work as advertised -; or, like Harvard's P.P.O., go off the rails along the way. Adverse selection is perhaps the direst threat. ... Healthier Americans will probably flock to cheaper bronze plans. And insurers will vie to enroll the healthy. In some states, big insurers have chosen not to participate in exchanges to avoid their strictures. On the outside, they could still sell cheap plans to skim off the healthy and avoid a rule that insurers on the exchanges must also offer more generous silver and gold plans (Eduardo Porter, 8/7).
Patients with advanced cancer are to test a therapy aimed at reducing their symptoms and improving quality of life.
In a new, multisite study of deaf children with cochlear implants, UT Dallas researchers have found that children with either no exposure or limited exposure to sign language end up with better auditory, speaking and reading skills later.
› Verified 5 days ago
| Entity Name | Wake Specialty Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942440375 PECOS PAC ID: 7416006085 Enrollment ID: O20090601000520 |
News Archive
A team of researchers has developed a method to produce cells that kill tumour cells in the lab and prevent tumours forming in mouse models of cancer. Although the current work is in cells and mouse, if the research transfers to human biology, the new type of cell could be a new source for cell-based anticancer therapies.
Yet despite the care the administration took in establishing incentives and safeguards, even some of Obamacare's most committed backers are wondering whether the experiment will work as advertised -; or, like Harvard's P.P.O., go off the rails along the way. Adverse selection is perhaps the direst threat. ... Healthier Americans will probably flock to cheaper bronze plans. And insurers will vie to enroll the healthy. In some states, big insurers have chosen not to participate in exchanges to avoid their strictures. On the outside, they could still sell cheap plans to skim off the healthy and avoid a rule that insurers on the exchanges must also offer more generous silver and gold plans (Eduardo Porter, 8/7).
Patients with advanced cancer are to test a therapy aimed at reducing their symptoms and improving quality of life.
In a new, multisite study of deaf children with cochlear implants, UT Dallas researchers have found that children with either no exposure or limited exposure to sign language end up with better auditory, speaking and reading skills later.
› Verified 5 days ago
| Entity Name | Wakemed Specialists Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588227839 PECOS PAC ID: 2466788377 Enrollment ID: O20190731000815 |
News Archive
A team of researchers has developed a method to produce cells that kill tumour cells in the lab and prevent tumours forming in mouse models of cancer. Although the current work is in cells and mouse, if the research transfers to human biology, the new type of cell could be a new source for cell-based anticancer therapies.
Yet despite the care the administration took in establishing incentives and safeguards, even some of Obamacare's most committed backers are wondering whether the experiment will work as advertised -; or, like Harvard's P.P.O., go off the rails along the way. Adverse selection is perhaps the direst threat. ... Healthier Americans will probably flock to cheaper bronze plans. And insurers will vie to enroll the healthy. In some states, big insurers have chosen not to participate in exchanges to avoid their strictures. On the outside, they could still sell cheap plans to skim off the healthy and avoid a rule that insurers on the exchanges must also offer more generous silver and gold plans (Eduardo Porter, 8/7).
Patients with advanced cancer are to test a therapy aimed at reducing their symptoms and improving quality of life.
In a new, multisite study of deaf children with cochlear implants, UT Dallas researchers have found that children with either no exposure or limited exposure to sign language end up with better auditory, speaking and reading skills later.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Theresa Cambre Amerson, MD 2920 Highwoods Blvd, Raleigh, NC 27604-0010 Ph: (877) 498-4490 | Theresa Cambre Amerson, MD 120 Healthplex Way, Apex, NC 27502-8403 Ph: (919) 350-0550 |
News Archive
A team of researchers has developed a method to produce cells that kill tumour cells in the lab and prevent tumours forming in mouse models of cancer. Although the current work is in cells and mouse, if the research transfers to human biology, the new type of cell could be a new source for cell-based anticancer therapies.
Yet despite the care the administration took in establishing incentives and safeguards, even some of Obamacare's most committed backers are wondering whether the experiment will work as advertised -; or, like Harvard's P.P.O., go off the rails along the way. Adverse selection is perhaps the direst threat. ... Healthier Americans will probably flock to cheaper bronze plans. And insurers will vie to enroll the healthy. In some states, big insurers have chosen not to participate in exchanges to avoid their strictures. On the outside, they could still sell cheap plans to skim off the healthy and avoid a rule that insurers on the exchanges must also offer more generous silver and gold plans (Eduardo Porter, 8/7).
Patients with advanced cancer are to test a therapy aimed at reducing their symptoms and improving quality of life.
In a new, multisite study of deaf children with cochlear implants, UT Dallas researchers have found that children with either no exposure or limited exposure to sign language end up with better auditory, speaking and reading skills later.
› Verified 5 days ago
Dr. Thusitha Ruwan Dissanayake, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Pemberton Hill Rd Ste 202, Apex, NC 27502 Phone: 919-760-5228 | |
Hersh Goel, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1051 Pemberton Hill Rd Ste 201, Apex, NC 27502 Phone: 919-200-0109 | |
Mehar Srivani Reddy Ambati, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1071 Pemberton Hill Rd, Suite 102, Apex, NC 27502 Phone: 919-363-6060 Fax: 919-363-6040 | |
Mr. Bal K Agarwal, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1011 W Williams St Ste 102, Apex, NC 27502 Phone: 919-794-4899 Fax: 828-633-0510 | |
Jill A Schaeffer, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1480 Kelly Rd, Apex, NC 27502 Phone: 919-363-9363 Fax: 919-363-9961 | |
Dr. Jangwon Lee, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 Healthplex Way Ste 204, Apex, NC 27502 Phone: 919-350-0550 Fax: 919-350-9822 |